UK Prime Minister Boris Johnson said on Monday that one significant hurdle has been cleared on the path to a vaccine for COVID-19, but there were still several more to overcome.
His comments come after the latest results released by New York-based Pfizer and German biotechnology company BioNTech show a vaccine candidate was strongly effective in a large phase 3 study.